Stay updated with breaking news from Ianf Smith. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Mr. Smith brings significant experience in the successful development and commercialization of medicines for rare genetic diseases –BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating prote...
Stoke Therapeutics, Inc. announced the appointment of Ian Smith to its Board of Directors effective September 19. Ian F. Smith is a director of Stoke Therapeutics. He serves as a Senior Advisor to...
– Mr. Smith brings significant experience in the successful development and commercialization of medicines for rare genetic diseases – ...
ViaCyte Appoints Michael Yang President and CEO and Provides Company Update - Michael Yang appointed President and CEO and to Board of Directors - Brittany Bradrick promoted to COO and CFO, and Steve White appointed CTO - Actively recruiting patients into Phase 2 clinical trials for PEC-Encap and PEC-Direct; supports timeline for topline data in 2H 2021 and 1H 2022, respectively - Company expands cell manufacturing capacity to support its current programs and research for new therapeutic indications News provided by Share this article , a clinical-stage regenerative medicine company, today a...